Home/Filings/4/0001193125-25-242571
4//SEC Filing

Porter James Richard 4

Accession 0001193125-25-242571

CIK 0001861560other

Filed

Oct 16, 8:00 PM ET

Accepted

Oct 17, 4:32 PM ET

Size

13.9 KB

Accession

0001193125-25-242571

Insider Transaction Report

Form 4
Period: 2025-10-16
Porter James Richard
DirectorPresident and CEO
Transactions
  • Sale

    Class A Common Stock

    2025-10-16$92.19/sh1,114$102,700249,762 total
  • Sale

    Class A Common Stock

    2025-10-16$92.63/sh700$64,841249,062 total
  • Sale

    Class A Common Stock

    2025-10-16$90.91/sh13,876$1,261,467250,876 total
  • Sale

    Class A Common Stock

    2025-10-16$90.01/sh11,310$1,018,013264,752 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2025-10-1627,000222,400 total
    Exercise: $18.93Exp: 2032-01-04Class A Common Stock (27,000 underlying)
  • Exercise/Conversion

    Class A Common Stock

    2025-10-16$18.93/sh+27,000$511,110276,062 total
Footnotes (6)
  • [F1]These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 2, 2024.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.56 to $90.55, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, Nuvalent, Inc. or any security holder of Nuvalent, Inc., upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) through (5) of this Form 4.
  • [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $90.56 to $91.47, inclusive.
  • [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.60 to $92.57, inclusive.
  • [F5]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $92.62 to $92.69, inclusive.
  • [F6]The shares underlying this option vest as follows: 25% of the shares vested on January 4, 2023, and the remainder have vested or shall vest over the three years thereafter in equal monthly installments, subject to continued service to Nuvalent, Inc. through the applicable vesting date.

Documents

1 file

Issuer

Nuvalent, Inc.

CIK 0001861560

Entity typeother

Related Parties

1
  • filerCIK 0001862900

Filing Metadata

Form type
4
Filed
Oct 16, 8:00 PM ET
Accepted
Oct 17, 4:32 PM ET
Size
13.9 KB